Scopus BioPharma Inc. (SCPS)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Mar 24, 2025, 11:51 AM

Scopus BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q4 2019	Q2 2019	Q1 2019
Period Ending	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Dec 31, 2019	Jun 30, 2019	Mar 31, 2019
Cash & Equivalents	362.1K	1.4M	124.58K	310.82K	1.16M	3.97M	7.94M	3.63M	6.26M	8.26M	1.83M	420.56K	36.75K	869.42K	546.48K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	562.00	25.61K	53.95K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	730.71K	n/a	n/a
Other Current Assets	133.76K	199.82K	265.43K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	750.13K	626.45K	393.85K	231.96K
Total Current Assets	495.85K	1.6M	390K	413.18K	1.67M	4.6M	8.18M	4.03M	6.8M	8.63M	1.97M	1.24M	768.02K	1.48M	1M
Property-Plant & Equipment	1.7K	2.03K	2.27K	2.5K	2.81K	3.41K	2.84K	3.17K	3.53K	1.91K	2.33K	2.6K	3.66K	2.25K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.7K	2.03K	2.27K	2.5K	2.81K	3.41K	2.84K	3.17K	3.53K	1.91K	2.33K	2.6K	3.66K	2.25K	n/a
Total Assets	497.55K	1.6M	392.26K	415.68K	1.67M	4.61M	8.19M	4.03M	6.81M	8.63M	1.97M	1.24M	771.68K	1.48M	1M
Account Payables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.8M	2.54M	2.28M	2.02M	n/a	n/a	n/a
Other Current Liabilities	93.18K	161.46K	252.51K	n/a	-5.37M	358.87K	n/a	n/a	3.41M	n/a	n/a	-1.76M	n/a	n/a	-1
Total Current Liabilities	11M	9.31M	7.45M	5.92M	5.37M	5.14M	4.17M	2.24M	8.79M	4.48M	3.81M	3.79M	854.54K	378.98K	363.64K
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	5.37M	n/a	n/a	n/a	2.8M	2.54M	2.28M	2.02M	n/a	n/a	n/a
Total Liabilities	11M	9.31M	7.45M	5.92M	5.37M	5.14M	4.17M	2.24M	8.79M	4.48M	3.81M	3.79M	854.54K	378.98K	363.64K
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.8M	2.54M	2.28M	2.02M	n/a	n/a	n/a
Common Stock	39.78K	39.58K	21.09K	21.09K	21.09K	21.09K	21.09K	18.09K	18.09K	15.73K	14.58K	14K	12.51K	12.36K	11.5K
Retained Earnings	-58.13M	-55.51M	-53.06M	-51.33M	-49.44M	-46.12M	-41.46M	-34.94M	-33.54M	-17.91M	-14.5M	-13.45M	-3.64M	-1.88M	-1.44M
Comprehensive Income	30.23K	13.47K	-4.95K	-2.68K	-12.03K	-68.79K	-86.65K	-66.05K	-60.46K	-48.09K	-68.07K	-35.93K	-33.45K	-10.24K	-6.87K
Shareholders Equity	-9.45M	-6.95M	-6.56M	-5.5M	-3.7M	-530.43K	4.02M	1.79M	-1.98M	4.15M	-1.83M	-2.55M	-82.86K	1.1M	640.88K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a